CD1D and neoplasm: iNKT cells exert anti-tumor effector cell activities by producing several Th1 cytokines, i.e. IFNγ, TNFα, and by eliminating CD1d-expressing tumor cells, thus they represent a potential intriguing therapeutic cellular tool against cancer development and metastasis [162].